Literature DB >> 15596490

Molecular modeling of nearly full-length ErbB2 receptor.

Péter Bagossi1, Gábor Horváth, György Vereb, János Szöllösi, József Tözsér.   

Abstract

Members of the epidermal growth factor receptor family play important roles in various cellular processes, both in physiological and in pathological conditions. Dimerization and autophosphorylation of these receptor tyrosine kinases are key events of signal transduction. Details of the molecular events of the signaling are not entirely known. To facilitate the understanding of receptor structure and function at the molecular level, a molecular model was built for the nearly full-length ErbB2 dimer. Modeling was based on the x-ray or nuclear-magnetic resonance structures of extracellular, transmembrane, and intracellular domains. The extracellular domain was positioned above the cell membrane based on the distance determined from experimentally measured fluorescence resonance energy transfer. Favorable dimerization interactions are predicted for the extracellular, transmembrane, and protein kinase domains in the model of a nearly full-length dimer of ErbB2, which may act in a coordinated fashion in ErbB2 homodimerization, and also in heterodimers of ErbB2 with other members of the ErbB family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15596490      PMCID: PMC1305137          DOI: 10.1529/biophysj.104.046003

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  67 in total

1.  Improved performance in protein secondary structure prediction by inhomogeneous score combination.

Authors:  Y Guermeur; C Geourjon; P Gallinari; G Deléage
Journal:  Bioinformatics       Date:  1999-05       Impact factor: 6.937

2.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 3.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 4.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 5.  Signal transduction and oncogenesis by ErbB/HER receptors.

Authors:  Mina D Marmor; Kochupurakkal Bose Skaria; Yosef Yarden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

6.  Extracellular domains drive homo- but not hetero-dimerization of erbB receptors.

Authors:  K M Ferguson; P J Darling; M J Mohan; T L Macatee; M A Lemmon
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

7.  Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2.

Authors:  Peter Nagy; György Vereb; Zsolt Sebestyén; Gábor Horváth; Stephen J Lockett; Sándor Damjanovich; John W Park; Thomas M Jovin; János Szöllosi
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

8.  Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation.

Authors:  Toru Kumagai; Makoto Katsumata; Akihiro Hasegawa; Keiji Furuuchi; Toshiki Funakoshi; Ichiro Kawase; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-16       Impact factor: 11.205

9.  A simple method for modeling transmembrane helix oligomers.

Authors:  Sanguk Kim; Aaron K Chamberlain; James U Bowie
Journal:  J Mol Biol       Date:  2003-06-13       Impact factor: 5.469

10.  Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation.

Authors:  P M Siegel; W J Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

View more
  10 in total

1.  Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity.

Authors:  Wanping Xu; Xitong Yuan; Kristin Beebe; Zhexin Xiang; Len Neckers
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

2.  Exploring the dynamics and interaction of a full ErbB2 receptor and Trastuzumab-Fab antibody in a lipid bilayer model using Martini coarse-grained force field.

Authors:  Juan Felipe Franco-Gonzalez; Javier Ramos; Victor L Cruz; Javier Martinez-Salazar
Journal:  J Comput Aided Mol Des       Date:  2014-08-17       Impact factor: 3.686

3.  Human epidermal growth factor receptor (EGFR) aligned on the plasma membrane adopts key features of Drosophila EGFR asymmetry.

Authors:  Christopher J Tynan; Selene K Roberts; Daniel J Rolfe; David T Clarke; Hannes H Loeffler; Johannes Kästner; Martyn D Winn; Peter J Parker; Marisa L Martin-Fernandez
Journal:  Mol Cell Biol       Date:  2011-03-28       Impact factor: 4.272

4.  Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations.

Authors:  Juan Felipe Franco-Gonzalez; Javier Ramos; Victor L Cruz; Javier Martínez-Salazar
Journal:  J Mol Model       Date:  2012-10-23       Impact factor: 1.810

5.  Atomistic insights into regulatory mechanisms of the HER2 tyrosine kinase domain: a molecular dynamics study.

Authors:  Shannon E Telesco; Ravi Radhakrishnan
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

Review 6.  Human epidermal growth factor receptor dimerization analysis in breast cancer diagnosis: potential for improving testing accuracy and treatment selection.

Authors:  Melanie Spears; John M S Bartlett
Journal:  Mol Diagn Ther       Date:  2009-12-01       Impact factor: 4.074

7.  Insight into the recognition patterns of the ErbB receptor family transmembrane domains: heterodimerization models through molecular dynamics search.

Authors:  Oumarou Samna Soumana; Norbert Garnier; Monique Genest
Journal:  Eur Biophys J       Date:  2008-03-26       Impact factor: 2.095

8.  ERBB2 in cat mammary neoplasias disclosed a positive correlation between RNA and protein low expression levels: a model for erbB-2 negative human breast cancer.

Authors:  Sara Santos; Cláudia S Baptista; Rui M V Abreu; Estela Bastos; Irina Amorim; Ivo G Gut; Fátima Gärtner; Raquel Chaves
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

9.  The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity.

Authors:  Gábor Tóth; Árpád Szöőr; László Simon; Yosef Yarden; János Szöllősi; György Vereb
Journal:  MAbs       Date:  2016-07-05       Impact factor: 5.857

10.  AccPbFRET: an ImageJ plugin for semi-automatic, fully corrected analysis of acceptor photobleaching FRET images.

Authors:  János Roszik; János Szöllosi; György Vereb
Journal:  BMC Bioinformatics       Date:  2008-08-19       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.